TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Scandinavian Biopharma Distribution AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
13,675
|
13,913
|
10,944 |
| Financial expenses |
50
|
36
|
45 |
| Earnings before taxes |
2,372
|
2,771
|
2,855 |
| EBITDA |
2,374
|
2,741
|
2,894 |
| Total assets |
6,862
|
7,526
|
6,084 |
| Current assets |
6,841
|
7,427
|
6,045 |
| Current liabilities |
1,903
|
2,398
|
2,517 |
| Equity capital |
88
|
87
|
85 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
5
|
4
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
1.3%
|
1.2%
|
1.4% |
| Turnover per employee |
2,735
|
3,478
|
3,648 |
| Profit as a percentage of turnover |
17.3%
|
19.9%
|
26.1% |
| Return on assets (ROA) |
35.3%
|
37.3%
|
47.7% |
| Current ratio |
359.5%
|
309.7%
|
240.2% |
| Return on equity (ROE) |
2695.5%
|
3185.1%
|
3358.8% |
| Change turnover |
235
|
2,937
|
2,470 |
| Change turnover % |
2%
|
27%
|
29% |
| Chg. No. of employees |
1
|
1
|
0 |
| Chg. No. of employees % |
25%
|
33%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.